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There is an increasing interest in the effect of dietary polyphenols on the intestinal micro-
biota and the possible associations between this effect and the development of some 
cardiovascular diseases, such as atherosclerosis (AS). However, limited information is 
available on how these polyphenols affect the gut microbiota and AS development. 
This study was designed to evaluate the modulation of dietary tea polyphenols (TPs) on 
intestinal Bifidobacteria (IB) and its correlation with AS development in apolipoprotein 
E-deficient (ApoE−/−) mice. Fifty C57BL/6 ApoE−/− mice were randomized into one of the 
five treatment groups (n = 10/group): control group fed normal diet (CK); a group fed a 
high-fat diet (HFD); and the other three groups fed the same HFD supplemented with 
TPs in drinking water for 16 weeks. The total cholesterol and low-density lipoprotein 
cholesterol (LDL-C) were decreased significantly (P < 0.05) after TP interference. In addi-
tion, the TP diet also decreased the plaque area/lumen area (PA/LA) ratios (P < 0.01) 
in the TP diet group. Interestingly, copies of IB in the gut of ApoE−/− mice were notably 
increased with TP interference. This increase was dose dependent (P < 0.01) and neg-
atively correlated with the PA/LA ratio (P < 0.05). We conclude that TPs could promote 
the proliferation of the IB, which is partially responsible for the reduction of AS plaque 
induced by HFD.
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inTrODUcTiOn
Atherosclerosis (AS) is a leading cause of death in Western countries, which is a complex patho-
phenotype governed by genetic and environmental determinants. High-fat diet (HFD) is one of 
the environmental risk factors for the development of AS, which may cause changes in the intes-
tinal microbial communities and may lead to obesity and low-grade intestinal inflammation (1). 
Abbreviations: AS, atherosclerosis; CK, normal diet group; HDL-C, high-density lipoprotein cholesterol; HFD, high-fat diet 
group; IB, intestinal Bifidobacteria; LDL-C, low-density lipoprotein-cholesterol; PA/LA, plaque area/lumen area; TC, total cho-
lesterol; TG, triglycerides; TPH, tea polyphenols high-dose group; TPL, tea polyphenols low-dose group; TPM, tea polyphenols 
medium-dose group; TPs, tea polyphenols.
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Moreover, the gut microbiota itself is an environmental risk factor 
for the development of AS (2).
Intestinal microbial communities may influence the effi-
ciency of dietary energy uptake and consequently influence 
susceptibility to obesity. A novel pathway linking dietary lipid 
intake, intestinal microbiota, and AS was identified, and the 
regulation of surface expression levels of macrophage scavenger 
receptors is well known to participate in the atherosclerotic 
process (3). Gut microbiota is also believed to be responsible for 
the control of metabolic endotoxemia, low-grade inflammation, 
and obesity (4). Additionally, a strong correlation has been 
observed between microbiota composition and AS develop-
ment (5, 6). Infection of Helicobacter cinaedi was found to alter 
expression of cholesterol receptors and transporters in cultured 
macrophages and caused foam cell formation, and enhanced 
AS in hyperlipidemic mice (7).
The principal component of AS plaques is lipids, which 
are derived from plasma lipids such as total cholesterol (TC), 
triglycerides (TG), and low-density lipoprotein cholesterol 
(LDL-C). High-density lipoprotein cholesterol (HDL-C) and 
LDL-C in serum are the major factors affecting the develop-
ment of AS lesions (8). The concentration of serum LDL-C is 
positively correlated with the incidence of AS (9). Serum TG 
may also promote plaque formation (10, 11), which further 
promotes AS (12). Bifidobacterium is one of the major genera of 
Actinobacteria that make up the colon microflora in mammals. 
Phylum Actinobacteria was considered to suppress inflamma-
tion and obesity (13, 14). Moreover, Bifidobacteria may produce 
short-chain fatty acids to decrease gut pH (15), form a biological 
barrier, and secret antimicrobial compounds to attenuate harm-
ful bacteria (16, 17). Populations of Bifidobacterium spp. are 
negatively correlated with serum TC and non-HDL-cholesterol 
level, autoantibodies against oxidized LDL, and AS lesion size 
(5). However, serum HDL-C level is positively correlated with 
Bifidobacterium spp. populations (5). Therefore, the diet pattern 
that modulates the intestinal Bifidobacteria (IB) may further 
influence the development of AS.
Tea polyphenols (TPs) contain catechins, flavonoids and 
flavonols, anthocyanins, and phenolic acids. They were identi-
fied to significantly reduce AS plaque area (18, 19) and have 
effects against coronary heart disease, high blood cholesterol 
concentrations, and high blood pressure (20). Loke et  al. 
hypothesized that polyphenols in foods can slow down the 
inflammatory response, which reduces NO bioavailability and 
therefore help ApoE−/− mice fight against AS (1). TPs may 
adjust the composition of the gut microbiome to maintain 
intestinal micro-ecological balance (21, 22), and protect 
and promote the development of probiotics (23, 24). This 
phenomenon has also been observed in other food-derived 
polyphenols (25).
We hypothesize that TPs may modulate fat metabolism 
and AS development by adjusting the gut Bifidobacteria in 
some degree. The present study was designed to understand 
the role of TPs on gut Bifidobacteria, lipid metabolism, and 
AS by using different dosages of TPs fed to ApoE−/− mice. 
The relationship among dietary TPs, gut Bifidobacteria, and 
AS was also explored.
MaTerials anD MeThODs
animals, Diet, and sample collection
Fifty 8-week-old-specific pathogen-free (SPF) C57BL/6 ApoE−/− 
mice were randomized into one of the five treatment groups 
(n  =  10/group, each half male and female): (1) high-dose 
TPs group (TPH), with 1.6  g/L of TP in the drinking water; 
(2) middle-dose TP group (TPM), with 0.8  g/L of TP in the 
drinking water; (3) low-dose TP group (TPL), with 0.4 g/L of 
TP in the drinking water; (4) high-fat control group (HFD); 
and (5) normal diet group (CK). In each group, 30 g/L sucrose 
was added to the drinking water to mask the bitterness of TP 
(19). The CK group was fed with regular feed (formulation is 
shown in Table S1 in Supplementary Material); the remaining 
four groups were fed a high-fat high-cholesterol feed (regular 
feed 83.25 g, fat 15 g, cholesterol 1.25 g, and cholic acid 0.5 g). 
The mice were housed in cages of the Third Military Medical 
University, Department of Experimental Animal Center of 
SPF animal house, at 23 ±  2°C with relative air humidity of 
50 ±  5% on a 12-h light–dark cycle. All feeds were sterilized 
by 60Co gamma radiation (42.5  millirad, Radiation Centre of 
Third Military Medical University).
The study was approved and supervised by the Ethics 
Committee of the Third Military Medical University Chongqing, 
China. SPF C57BL/6 ApoE−/− mice (No. SCXK 2012-0003; SYXK 
2012-0002) used in this study were provided by the Department 
of Laboratory Animal Science of the Third Military Medical 
University.
Drinking water was replaced daily according to the formula-
tion, and food consumption and body weight changes were 
recorded weekly. Two to five feces pellets from each cage were 
weekly collected stored in micro-tubes at −80°C until use.
Tea polyphenols were provided by Jiangxi Lvkang Natural 
Products Co., Ltd., Yichun, China (main components are shown 
in Table S2 in Supplementary Material).
Dna extraction
Approximately 20  mg of mice fecal sample was enclosed in a 
pre-aseptic 2-mL screw-cap tube (Axygen, Union City, CA, 
USA) with 0.1-g zirconia beads (diameter of 0.1 mm, BioSpec, 
Bartlesville, OK, USA), 250 μL lysis buffer (0.5M NaCl, 50 mM 
EDTA, 50  mM Tris–HCl pH 8.0, and 4% SDS), and 100  μL 
phenol:chloroform:isoamyl alcohol (25:24:1) (v/v). Specimens 
were homogenized with a MiniBeadBeater-16 (BioSpec) for 
2 min at maximum speed, and then 1–5 μL of DNA-free RNAase 
(10 mg/μL) was added to remove residual RNA. The DNA was 
purified with a phenol–chloroform extraction. The DNA concen-
tration was measured with a NanoDrop ND-1000 spectropho-
tometer (Thermo, Wilmington, DE, USA) at 260 and 280 nm, and 
DNA integrity was examined by electrophoresis in 0.8% (w/v) 
agarose gels (26).
apoe−/− Mice abdominal aorta section 
and atherosclerosis Plaque analysis
After treatment for 16 weeks, ApoE−/− mice were anesthetized, 
their limbs were fixed on an anatomic plate, and their chest and 
abdomen were disinfected with 75% ethanol. After the thoracic 
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cavity was opened to expose the heart, the left ventricle and right 
atrial appendage were cut. A perfusion needle was immediately 
inserted into the left ventricle after the cut to perfuse saline 
and 10% formaldehyde into heart for 40  min. About 10-mm 
specimens were cut from the abdominal aorta, fixed with 10% 
formalin, and embedded in paraffin after 48 h. Each aorta sample 
was stained with hematoxylin–eosin (HE) (27). The lesion area 
was measured by means of direct image capture from optical 
microscopy (Nikon digital system, Tokyo, Japan) and quantified 
using Image Pro Plus 6.0 (Media Cybernetics, Warrendale, PA, 
USA) software.
serum lipid and lipoprotein analyses
After 16 weeks, 3ApoE−/− mice were randomly selected from each 
group and anesthetized with 0.5% barbital sodium solution, and 
0.2-mL whole blood samples from each mouse were drawn and 
stored in sterilized Eppendorf tubes. The blood was allowed to clot 
at room temperature before the serum was separated by centrifu-
gation at 1000 g for 10 min. Serum was transferred to sterilized 
Eppendorf tubes and stored at −80°C until use. Serum parameters 
were determined by an Olympus Biochemical Auto-analyzer 
(Olympus AU 2700 Auto-analyzer, Olympus Corporation, Tokyo, 
Japan) using reagents from Olympus Diagnostics (28).
Quantitation of Bifidobacteria
A Bifidobacteria genus quantitative PCR standard curve was 
established by cloning a standard Bifidobacterium strain 
Bifidobacterium breve LMG11042 16S rRNA gene into a pMD19-
T vector, as Bartosch et  al. previously described (29). Plasmid 
standards and samples were assayed simultaneously in triplicate.
The qrT-Pcr analysis of Bifidobacterium
16S rRNA genes was extracted by using SYBR PCR reagents; the 
extracted genes were then analyzed by an iCycleriQ real-time 
detection system (Bio-Rad, Hercules, CA, USA) compatible with 
the iCycler Optical System Interface software program (Bio-Rad) 
and Bifidobacterium primers (Bifid-real F, 5′-GCGTGCTTAA 
CACATGCAAGTC-3′; Bifid-real R, 5′-CACCCGTTTCCAGGA 
GCTATT-3′) (30). The 20-μL reaction mixture contained 2-μL 
DNA (diluted plasmid standards or samples), 0.2  μM of each 
primer, and appropriate amounts of other reagents as recom-
mended by the manufacturer. The PCR thermocycling was 
programed to run the first cycle at 95°C for 3 min, followed by 35 
cycles of denaturation at 95°C for 30 s, and annealing/elongation 
at 60°C for 1 min. After amplification, melting curve analysis of 
the PCR products was performed from 60 to 94°C, with incre-
ments of 0.5°C per 10 s. The copy number of the target sequence 
was calculated as previously described (31).
statistical analysis
Statistical analysis was performed using GraphPad Prism 
Software for Windows OS (version 6.05, Graphpad Software, 
La Jolla, CA, USA). Statistically significant differences between 
serum TC, TG, HDL-C, and LDL-C content and AS plaque 
area between the five treatment groups were determined by the 
non-parametric one-way ANOVA test with default parameters 
all the time. The Tukey’s multiple comparisons test was used for 
multiple pairwise comparisons and a dose–response relation-
ship. A dose–response meta-analysis was performed to examine 
a potential non-linear relationship between TP dose, AS plaque 
area, and LgN (copies of Bifidobacteria), and a dose–response 
meta-analysis was conducted using generalized least squares 
regression test with EViews Software for Windows (version 8.0, 
IHS Global GNC, PA, USA). P < 0.05 was considered statistically 
significant.
resUlTs
Body Weight and Feed consumption 
of apoe−/−Mice
ApoE−/− mice mean consumption of high-fat feed was less than 
that of the CK group, and the HFD and TPH groups had sig-
nificantly lower food consumption (P < 0.05) in the first week 
(Figure  1A). However, the difference in feed consumption per 
week among TPH, TPM, TPL, HFD, and CK groups were not 
statistically different from the second week and over the whole 
study (P >  0.05) (Figure  1B). Figure  1C shows that the mean 
body weight of the TP group (TPH, TPM, and TPL) and HFD 
group were significantly lower than the CK group (P < 0.05) from 
the first week to the fourth week. The ApoE−/− mice in the HFD 
group gained weight faster than the other groups from 5th week 
and had the highest weight from the 11th week to the end of the 
study. However, this difference was not significant (P > 0.05).
Tc, Tg, hDl-c, and lDl-c of apoe−/− 
Mice serum
The effect of treatments on lipid parameters is demonstrated 
in Figure  2. After a HFD for 16  weeks, the mean serum TC 
(36.4 ± 12.2 mmol/L), LDL-C (28.4 ± 10.8 mmol/L), and HDL-C 
(4.1 ± 1.4 mmol/L) levels in the HFD group were significantly 
higher than those in the CK group (18.4 ± 0.7, 15.5 ± 0.6, and 
2.1 ± 0.1 mmol/L, respectively) (P < 0.05).
No significant difference in serum TG level was found between 
the HFD and CK group. In the TPL group, no significant dif-
ference in lipid parameters was observed compared to the HFD 
group. The serum TC, LDL-C, and HDL-C levels were signifi-
cantly lower among the TPH and TPM groups, when comparing 
to the HFD group (P < 0.05).
However, TG levels in the TPH, TPM, and TPL groups were 
2.0 ± 0.5, 1.9 ± 0.2, and 1.5 ± 0.1 mmol/L, respectively, with no 
significant differences among the TPH, TPM, TPL, and HFD 
groups (P > 0.05) (Figure 2B).
If the mice consume 0.25-mg TPs per gram body weight per 
day, it will get better protection on AS. These results are calculated 
from the following fact: each mouse consumes about 4-mL (con-
tain 1.6 g/L TPs) water; each mouse’s average body weight is 25 g.
atherosclerosis Plaques in apoe−/−Mice 
abdominal aortas
ApoE−/− mice abdominal aorta AS lesion progression was 
assessed by AS plaque size, intimal and medial integrity, and 
foam cell morphology observed by optical microscopy. The 
results indicated an association between the fat content in the 
FigUre 1 | effects of diet with tea polyphenol on feed consumption and body weight of c57Bl/6 apoe−/− mice. (a) Feed consumption in 1st week; 
(B) feed consumption in the whole period; (c) body weight per mouse. Bars represent means ± SEM, n = 10. (a,b) Different lowercase letters indicate significant 
differences (p < 0.05); the same lowercase letter indicates that the difference is not significant (p > 0.05); *means significant differences compared with CK group 
(p < 0.05).
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feed and development of AS lesions: the PA/LA ratio in the HFD 
group was 0.69 ± 0.18, whereas no AS plaques were observed in 
the CK group. The ruptured foam cells formed AS plaques which 
accumulated in the intimal membrane, thus causing narrower 
blood vessels in mice of the HFD group. Therefore, the AS model 
in ApoE−/− mice was successfully constructed with the HFD. 
After 16 weeks of treatment with TPs, microscopic analyses of 
the abdominal aorta lesions showed that atherosclerotic lesion 
development was retarded by dietary TP. AS plaque area in the 
abdominal aorta among TP fed groups were smaller than those 
in the HFD group (Figure 3). The PA/LA ratios in the TPL, TPM, 
and TPH groups were 0.36 ± 0.07, 0.10 ± 0.01, and 0.06 ± 0.02, 
respectively, and were significantly lower than those of the HFD 
group (0.69 ± 0.18) (P < 0.01) (Figure 4). No significant differ-
ence of AS lesion between the TPH and TPM groups (P > 0.05) 
was shown in this study; however, the AS lesion in TPH and 
TPM groups were significantly lower than that of the TPL group 
(P < 0.05).
copies of Bifidobacteria in the 
apoe−/−Mouse gut
The number of copies of Bifidobacteria was 1.31 ±  0.32 log 
copies/ng in feces of the HFD group, which was significantly 
lower than that in the CK group (2.03  ±  0.17 log copies/
ng, P  <  0.01). Therefore, a HFD may lower the amount of 
Bifidobacteria in the ApoE−/− mouse gut. After a 16-week TP 
diet, Bifidobacteria copies in the TPL (2.46 ± 1.80 log copies/
ng, P < 0.01), TPM (4.67 ± 0.23 log copies/ng, P < 0.001), and 
TPH (4.87 ±  0.23 log copies/ng, P <  0.001) groups were all 
significantly higher than that in the HFD group. Furthermore, 
copies in the TPM and TPH groups were markedly higher than 
those in the TPL group (P < 0.01), but there was no significant 
different between copy numbers in the TPH and TPM groups 
(P > 0.05). This illustrates that TP could increase copy numbers 
of Bifidobacteria in the ApoE−/− mouse gut dose-dependently 
(Figure  4B).
non-linear Dose–response analyses 
of TP, iB copies, and as Plaque
There was a significant non-linear dose–response association 
observed between AS plaque PA/PL value and the dose of 
TP (R2 =  0.9033, P =  0.0496) (Figure  5A), and it is also sig-
nificant between PA/PL value and Bifidobacteria copy number 
(R2 = 0.9773, P = 0.0114) (Figure 5C); however, there no statisti-
cally significance between TP dose and the Bifidobacteria copy 
number (R2 = 0.9059, P = 0.4839) (Figure 5B).
FigUre 3 | cross-sections of abdominal aorta stained by he staining from c57Bl/6 apoe−/− mice fed a normal diet (a), a high-fat diet (B) and tea 
polyphenols diet (c–e) for 16 weeks. Representative photographs are also shown for abdominal aorta AS plaque area in C57BL/6 ApoE−/− mice of CK group 
(a,a1), HFD group (B,B1), TPL group (c,c1), TPM group (D,D1), TPH group (e,e1). Note: black triangle (►) is shown for intimal membrane protuberance; solid 
black arrows () indicate AS material; and feint arrows () indicate foam cells.
FigUre 2 | effect on the serum levels in the c57Bl/6 apoe−/− mice after diet with tea polyphenol 16 weeks. (a) TC; (B) TG; (c) LDL-C; and (D) HDL-C. 
Bars represent means ± SEM, n = 3. (a,b) Different lowercase letters indicate significant differences (p < 0.05); the same lowercase letter indicates that the 
difference is not significant (p > 0.05).
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DiscUssiOn
Tea polyphenols, the most important bioactive ingredients pre-
sent in tea, are believed to exert a diversity of beneficial effects 
in preventing the development of AS (32, 33). LDL-C is the most 
significant risk factor for AS development: LDL-C can be oxidized 
into ox-LDL, which may then interact with the scavenger receptors 
of macrophages and vascular smooth muscle membranes in the 
arterial wall. This interaction leads to the formation of fat-derived 
and muscle-derived foam cells; an AS plaque will develop due to 
FigUre 5 | interaction between as, iB, and TP. (a) Correlations between TP doses and PA/PL ratio; (B) correlation between Bifidobacteria copies and PA/PL 
ratio; (c) correlation between TP doses and Bifidobacteria copies; the C57BL/6 ApoE−/− mice fed a high-fat and tea polyphenols diet for 16 weeks. Bars represent 
means ± SEM, n = 3, (a) P = 0.0496, (B) P = 0.4839, and (c) P = 0.0114.
FigUre 4 | abdominal aorta as plaque area and lumen area ratio (Pa/la, P < 0.01) in the c57Bl/6 apoe−/− mice diet with tea polyphenol for 
16 weeks (a). After a 16-week TP diet, Bifidobacteria copies in the TPL (P < 0.01), TPM (P < 0.001), and TPH (P < 0.001) groups were all significantly higher than 
that in the HFD (P < 0.01) group (B). Bars represent means ± SEM, n = 10. (a,b,c) Different lowercase letters indicate significant differences (p < 0.05); the same 
lowercase letter indicates that the difference is not significant (p > 0.05).
6
Liao et al. Tea Polyphenols on Atherosclerosis and Gut Bifidobacteria
Frontiers in Nutrition | www.frontiersin.org December 2016 | Volume 3 | Article 42
the accumulation of the foam cell (34). It is believed that TPs may 
alleviate lipid metabolic abnormalities by reducing LDL-C levels 
(35) and inhibiting LDL-C oxidation (32, 33). The results of this 
study showed that TP could significantly retard AS lesion forma-
tion in ApoE−/− mouse abdominal aorta. Moreover, the dose of TP 
was negatively correlated with the area of AS lesions.
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Atherosclerosis is also considered as a type of chronic inflam-
mation (36), which is closely related to metabolic diseases such as 
obesity and diabetes (36–38). In recent years, increasing evidence 
has found an association between metabolic disease and intesti-
nal flora (39, 40). However, no study has fully demonstrated the 
relationship among the dietary polyphenols, the gut microbiota, 
and the development of AS. The further possible mechanism of 
TPs can inhabit AS development maybe the anti-inflammatory 
ability of itself.
Diet is the main environmental factor impacting the gut 
microbiome composition. We investigated the effects of a TP 
diet on ApoE−/− mice fed a HFD, and our results showed that TP 
can dramatically increase the amount of gut Bifidobacteria. Lee 
(23) reported that growth of certain pathogenic bacteria, such 
as Clostridium perfringens, Clostridium difficile, and Bacteroides 
spp., was significantly repressed by TPs, while Bifidobacterium 
spp. and Lactobacillus spp. were less severely affected. According 
to the result that different intestinal bacteria had varying degrees 
of sensitivity to TPs, we concluded that TPs can increase the 
number of Bifidobacteria. It has been shown that Bifidobacteria 
species have beneficial effects on cardiovascular health. B. breve 
may significantly reduce the serum TC level when given to obese 
mice induced by HFD (14). In this study, we found that TP diet 
significantly reduced serum TC and LDL-C levels of ApoE−/− mice 
(P < 0.05). Meanwhile, a recent metabolomic study indicated that 
product(s) yielded from microbial metabolism of lipids in the gut 
may promote AS (3).
It was believed that the serum HDL-C level is positively 
correlated with the existence of Bifidobacteria populations in 
the gut (5). However, this study found that TP diet significantly 
decreased (P < 0.05) the serum HDL-C levels in mice. A possible 
explanation is that TP diet decreases the serum cholesterol level, 
thus lowering the serum HDL-C level. HDL-C plays a key role in 
removing cholesterol from cholesterol-loaded macrophages, thus 
preventing the accumulation of arterial plaque (41, 42). When 
ApoE−/− mice were fed with a HFD, the serum cholesterol level 
was elevated. This elevation induced the production of the HDL 
particles. Other studies have also found that a HFD may induce 
an elevation in serum HDL-C level (43), while a low-fat diet may 
decrease the serum HDL-C level (44).
Epidemiological studies have also showed that serum HDL-C 
level is inversely correlated with risk of cardiovascular events 
(41). However, our investigation demonstrated that the elevated 
serum HDL-C level in the HFD group did not play a protective 
role in preventing the formation of abdominal aorta AS plaques 
in ApoE−/− mice (Figure 4A). It is important to note that HDL-C 
particles in ApoE−/− mice are abnormal and disrupted (45) due 
to the lack of ApoE. The lack of ApoE in the HDL particles leads 
to a weaker cholesterol efflux capacity (the ability to remove 
cholesterol from cholesterol-loaded macrophages) (46–48). 
Hence, the formation of abdominal aorta AS plaques is expected. 
Furthermore, it is well known that AS is strongly associated with 
obesity. Zhao and his colleagues reported that Bifidobacteria may 
reduce fat accumulation (49). It was observed that the abundance 
of Bifidobacteria in the mouse gut declined significantly due to 
HFD feeding (50, 51). This phenomenon was also observed in our 
study (Figure 4B). A dose-dependent effect was found between 
the dietary TP and the number of Bifidobacteria in this study. The 
AS plaque PA/PL value was significantly and negatively correlated 
with the Bifidobacteria count. The dominant Bifidobacteria species 
in the ApoE−/− mouse gut is Bifidobacterium pseudolongum (52). 
We make a putative opinion that TP could induce a Bifidobacteria 
boom, which could prevent AS development by modulating the 
fat metabolism. This process could be a part of the mechanism of 
the effect of TP on cardiovascular health.
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